Postural Orthostatic Tachycardia Syndrome (POTS) - A novel member of the autoimmune family

Lupus

Volumn 25, Issue 4, 2016, Pages 339-342

  Dahan, S ^a,b   Tomljenovic, L ^c   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

autoantibodies; autoimmunity; chronic fatigue syndrome (CFS); human papilloma virus (HPV); molecular mimicry; Postural orthostatic tachycardia syndrome (POTS)

Indexed keywords

ANXIETY DISORDER; AUTOIMMUNE DISEASE; AUTONOMIC NERVOUS SYSTEM; BRAIN PERFUSION; CHRONIC DISEASE; DISEASE ASSOCIATION; HEART RATE; HUMAN; PANIC; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; REVIEW; STANDING; SUPINE POSITION; TACHYCARDIA; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BRAIN CIRCULATION; CROSS REACTION; DEATH, SUDDEN, CARDIAC; IMMUNOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

CAPSID PROTEIN; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; WART VIRUS VACCINE;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CAPSID PROTEINS; CEREBROVASCULAR CIRCULATION; CROSS REACTIONS; DEATH, SUDDEN, CARDIAC; HEART RATE; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; RISK FACTORS; SUPINE POSITION;

EID: 84960417276     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316629558     Document Type: Review

References (47)

1. Grubb BP, Kanjwal Y, Kosinski DJ,. The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol 2006; 17: 108-112.
2. Low PA, Sandroni P, Joyner M, Shen WK,. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 2009; 20: 352-358.
3. Raj SR,. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis and management. Indian Pacing Electrophysiol J 2006; 6: 84-99.
4. Schondorf R, Benoit J, Wein T, Phaneuf D,. Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst 1999; 75: 192-201.
5. Hoad A, Spickett G, Elliott J, Newton J,. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. Q J Med 2008; 101: 961-965.
6. Stewart JM, Gewitz MH, Weldon A, Munoz J,. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999; 135 (2 Pt 1): 218-225.
7. Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clinic Proc 2007; 82: 308-313.
8. Schondorf R, Freeman R,. The importance of orthostatic intolerance in the chronic fatigue syndrome. Am J Med Sci 1999; 317: 117-123.
9. Kimpinski K, Figueroa JJ, Singer W, et al. A prospective, 1-year follow-up study of postural tachycardia syndrome. Mayo Clin Proc 2012; 87: 746-752.
10. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP,. Autonomic dysfunction presenting as postural tachycardia syndrome following traumatic brain injury. Cardiol J 2010; 17: 482-487.
11. Mosnaim AD, Abiola R, Wolf ME, Perlmuter LC,. Etiology and risk factors for developing orthostatic hypotension. Am J Ther 2009; 17: 86-91.
12. Blitshteyn S,. Postural tachycardia syndrome after vaccination with Gardasil (letter to the editor). Eur J Neurol 2010; 17: e52-e52.
13. Tsai CK, Chu H, Cheng CA,. Novel H1N1 influenza vaccine the cause of postural orthostatic tachycardia syndrome followed by cerebral hypoperfusion. J Med Sci 2011; 31: 91-93.
14. Agmon-Levin N, Shoenfeld Y,. Chronic fatigue syndrome with autoantibodies: the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev 2008; 8: 52-55.
15. Exley C, Swarbrick L, Gherardi RK, Authier FJ,. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 2009; 72: 135-139.
16. Rosenblum H, Shoenfeld Y, Amital H,. The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA syndrome. Infect Dis Clin N Am 2011; 25: 851-863.
17. Nishikai M, Tomomatsu S, Hankins RW, et al. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Rheumatology 2001; 40: 806-810.
18. Nishikai M, Kosaka S,. Incidence of antinuclear antibodies in Japanese patients with chronic fatigue syndrome. Arthritis Rheum 1997; 40: 2095-2097.
19. Nishikai M,. Antinuclear antibodies in patients with chronic fatigue syndrome. Nihon Rinsho 2007; 65: 1067-1070.
20. Otokida K, Yoshida H, Sato N, et al. Acute autonomic neuropathy associated with a high serum bradykinin level and positive anti-nuclear and anti-DNA antibodies titers. Jpn J Med 1990; 29: 560-565.
21. Wang XL, Chai Q, Charlesworth MC, et al. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteomics Clin Appl 2012; 6: 615-625.
22. Li H, Khan MA, Vanderlinde-Wood MD, et al. Autonomic autoantibodies with allosteric activity in idiopathic postural orthostatic hypotension (IOH) and tachycardia syndrome (POTS): a new mechanism. Endocrine Rev 2012; 33: OR48-1.
23. Yu X, Stavrakis S, Hill MA, et al. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J Am Soc Hypertens 2012; 6: 40-47.
24. Deutsch M, Guejes L, Zurgil N, et al. Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis. Clin Exp Rheumatol 2004; 22 (6 Suppl 36): S35-S40.
25. Weisbart RH, Baldwin R, Huh B, Zack DJ, Nishimura R,. Novel protein transfection of primary rat cortical neurons using an antibody that penetrates living cells. J Immunol 2000; 164: 6020-6026.
26. Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y,. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases. Lupus 2012; 21: 146-152.
27. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP,. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. Int J Med Sci 2010; 7: 62-67.
28. Calabrese LH, Davis ME, Wilke WS,. Chronic fatigue syndrome and a disorder resembling Sjorgen's syndrome: preliminary report. Clin Infect Dis 1994; 18 (Suppl 1): S28-S31.
29. Tang S, Calkins H, Petri M,. Neurally mediated hypotension in systemic lupus erythematosus patients with fibromyalgia. Rheumatology 2004; 43: 609-614.
30. Mallipeddi R, Mathias CJ,. Raynaud's phenomenon after sympathetic denervation in patients with primary autonomic failure: questionnaire survey. BMJ 1998; 316: 438-439.
31. Petri M, Rowe P, Calkins H,. Chronic fatigue in SLE may be a manifestation of autonomic neuropathy. Arthritis Rheum 2000; 43 (Suppl. 9): 1-4.
32. US VAERS database. Available from: https://vaers.hhs.gov/index.
33. (CDC) CfDCaP. Information from FDA and CDC on Gardasil and its safety (archived). Last updated: February 7, 2011. Available from: http://www.cdc.gov/vaccinesafety/Vaccines/HPV/HPVArchived.html.
34. MHRA. Vaccine associated suspected adverse reactions reported via the Yellow Card scheme during 2009. Paper provided for Joint Committee on Vaccination and Immunisation, June 2010.
35. Authier FJ, Sauvat S, Champey J, Drogou I, Coquet M, Gherardi RK,. Chronic fatigue syndrome in patients with macrophagic myofasciitis. Arthritis Rheum 2003; 48: 569-570.
36. Kanduc D,. Potential cross-reactivity between HPV16 L1 protein and sudden death-associated antigens. J Exp Ther Oncol 2011; 9: 159-165.
37. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004; 36: 1162-1164.
38. Syrris P, Ward D, Evans A, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 2006; 79: 978-984.
39. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G,. Right bundle branch block, right precordial st-segment elevation, and sudden death in young people. Circulation 2001; 103: 710-717.
40. Cho Y, Park T, Yang DH, et al. Arrhythmogenic right ventricular cardiomyopathy and sudden cardiac death in young Koreans. Circ J 2003; 67: 925-928.
41. Nucifora G, Benettoni A, Allocca G, Bussani R, Silvestri F,. Arrhythmogenic right ventricular dysplasia/cardiomyopathy as a cause of sudden infant death. J Cardiovasc Med 2008; 9: 430-431.
42. Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999; 20: 465-470.
43. Paul M, Meyborg M, Boknik P, et al. Autonomic dysfunction in patients with Brugada syndrome: further biochemical evidence of altered signaling pathways. Pacing Clin Electrophysiol 2011; 34: 1147-1153.
44. Kanduc D,. Peptide cross-reactivity: the original sin of vaccines. Front Biosci (Schol Ed) 2012; 4: 1393-1401.
45. Kanduc D,. Quantifying the possible cross-reactivity risk of an HPV16 vaccine. J Exp Ther Oncol 2009; 8: 65-76.
46. Trost B, Lucchese G, Stufano A, Bickis M, Kusalik A, Kanduc D,. No human protein is exempt from bacterial motifs, not even one. Self Nonself 2010; 1: 328-334.
47. Trost B, Kusalik A, Lucchese G, Kanduc D,. Bacterial peptides are intensively present throughout the human proteome. Self Nonself 2010; 1: 71-74.